(S)-2-(3-Isobutylphenyl)propanoic acid | 342373-94-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: (S)-2-(3-Isobutylphenyl)propanoic acid
• 英文别名: (2S)-2-[3-(2-methylpropyl)phenyl]propanoic acid
• CAS: 342373-94-8
• 化学式: C₁₃H₁₈O₂
• 分子量: 206.285
• InChiKey: SFVKLYXPBKITCE-JTQLQIEISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  ibuprofen 2-chloroethyl ester 在 lipase OF I 作用下， 以 水 为溶剂， 反应 36.0h， 生成 (S)-2-(3-Isobutylphenyl)propanoic acid 、 (R)-2-(3-Isobutyl-phenyl)-propionic acid
  参考文献：
  名称：

  Enhancement of the enantioselectivity of lipase OF catalyzed hydrolysis

  摘要：

  By rational purification of lipase OF on a mercurial affinity column three fi actions were identified as responsible for the improved enantioselectivity without compromising the total activity of the crude enzyme. These three portions of lipase OF have remarkably different abilities to differentiate between the enantiomers of alpha -arylpropionic acids in the lipase catalyzed hydrolysis of the corresponding esters. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(01)00017-9

文献信息

• NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS
  申请人：Stewart Andrew O.

  公开号：US20100130558A1

  公开（公告）日：2010-05-27

  The present application relates to calcium channel inhibitors containing compounds of formula (I) wherein L 1 , L 2 , R 1 , R 2 , and R 3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

  本申请涉及含有式（I）化合物的钙通道抑制剂，其中L1、L2、R1、R2和R3如规范中所定义。本申请还涉及包含这种化合物的组合物，以及使用这种化合物和组合物治疗疾病和疾病的方法。
• 2-Aryl-propionic acids and pharmaceutical compositions containing them
  申请人：Allegretti Marcello

  公开号：US20050038119A1

  公开（公告）日：2005-02-17

  (R) and (S) 2-Aryl-propionic acids, and pharmaceutical compositions that contain them, are useful in inhibiting chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8) with CXCR1 and CXCR2 membrane receptors. The acids are used for the prevention and treatment of pathologies deriving from said activation. In particular, the (R) enantiomers of said acids are lacking cyclo-oxygenase inhibition activity and are particularly useful in the tratment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.

  (R)和(S) 2-芳基-丙酸以及含有它们的制药组合物，在抑制由白细胞介素-8（IL-8）与CXCR1和CXCR2膜受体相互作用引起的嗜中性粒细胞（PMN白细胞）趋化激活方面非常有用。这些酸用于预防和治疗由该激活引起的病理状况。特别是，这些酸的(R)对映体缺乏环氧合酶抑制活性，特别适用于治疗依赖于嗜中性粒细胞的病理状况，如牛皮癣，溃疡性结肠炎，黑色素瘤，慢性阻塞性肺疾病（COPD），水疱性天疱疮，类风湿性关节炎，特发性纤维化，肾小球肾炎以及缺血再灌注所致的损伤的预防和治疗。
• Garot, C.; Javed, T.; Mason, T. J., Bulletin des Societes Chimiques Belges, 1996, vol. 105, # 12, p. 755 - 758
  作者：Garot, C.、Javed, T.、Mason, T. J.、Turner, J. L.、Cooper, J. W.

  DOI：——

  日期：——
• EP1638505A4
  申请人：——

  公开号：EP1638505A4

  公开（公告）日：2009-01-07
• AMPHIPHILIC PYRIDINIUM COMPOUNDS, METHOD OF MAKING AND USE THEREOF
  申请人：HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.

  公开号：EP1638505A2

  公开（公告）日：2006-03-29